{{Rsnum
|rsid=1329568
|Gene=POMT2
|Chromosome=9
|position=37037979
|Orientation=minus
|GMAF=0.06152
|Gene_s=POMT2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 0.0 | 0.9 | 99.1
| HCB | 0.0 | 8.1 | 91.9
| JPT | 0.0 | 6.2 | 93.8
| YRI | 3.4 | 45.9 | 50.7
| ASW | 5.3 | 35.1 | 59.6
| CHB | 0.0 | 8.1 | 91.9
| CHD | 0.0 | 9.3 | 90.7
| GIH | 0.0 | 0.0 | 0.0
| LWK | 6.5 | 26.2 | 67.3
| MEX | 0.0 | 0.0 | 0.0
| MKK | 7.1 | 43.5 | 49.4
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22491018
|Trait=None
|Title=Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.
|RiskAllele=
|Pval=8E-7
|OR=19.6400
|ORtxt=None
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}